BioMarin Pharmaceutical I...

68.35
0.41 (0.60%)
At close: Apr 02, 2025, 3:59 PM
66.45
-2.78%
After-hours: Apr 02, 2025, 06:12 PM EDT

BioMarin Pharmaceutical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007 Dec 31, 2006 Dec 31, 2005 Dec 31, 2004 Dec 31, 2003 Dec 31, 2002 Dec 31, 2001 Dec 31, 2000 Dec 31, 1999 Dec 31, 1998
Net Income 426.86M 167.65M 141.56M -64.08M 859.1M -23.85M -77.21M -117.04M -630.21M -171.8M -133.97M -176.35M -114.35M -53.84M 205.82M -488K 30.83M -15.8M -28.53M -74.27M -187.44M -76.38M -77.37M -57.43M -37.36M -28.07M -12.3M
Depreciation & Amortization 96.43M 104.39M 101.97M 108.04M 105.17M 105.3M 95.67M 87.86M 96.91M 47.19M 56.74M 47.26M 45.3M 36.09M 27.74M 20.98M 17.63M 1.09M 11.96M 10.07M 13.28M 9.44M 8.5M 7M 7.33M 6.56M 800K
Stock-Based Compensation 202.51M 207.1M 196.31M 197.26M 189.71M 159.87M 148.82M 140.26M 134.64M 111.53M 88.23M 66.18M 47.34M 43.91M 38.36M 36.01M 28.34M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -184.16M -57.9M -5.1M -15.65B -35.52M -5.77M 7.98M 3.35M -10.39M -2.41M -3.34M 11.23M 1.96M 1.13M -3.43M 36.59M -2.1M -5.84M -15.35M 16.09M 4.26M -6.31M -1.97M -2.7M 469K 1.61M 900K
Other Non-Cash Items 7.34M 61.65M -115.47M 12.89M 44.71M -9.2M -29.27M -70.34M 559.15M -178.11M -28.72M 35.51M 16.18M 13.32M 19.5M 2.04M -15K -6.57M -3.99M -5.99M 104.76M -1.56M 17.24M 30.06M 16.43M 6.97M 2.6M
Deferred Income Tax 56.1M -44.98M -52.09M -15.61M -888.91M -82.76M -68.38M 44.46M -228.05M -76.83M -25.48M -9.16M -9.92M 4.36M -230.58M 9.32M 3.03M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital -216.4M -336.54M -96.38M 66.03M -224.42M -101.09M -49.42M -93.96M -160.28M 46.33M -30.34M -23.08M 33.06M -25.1M -42.09M 19.87M -88.99M -13.21M -29.52M 7.5M 4.26M -6.31M -1.97M -2.7M 709K 1.6M 800K
Operating Cash Flow 572.84M 159.26M 175.9M 304.54M 85.36M 48.26M 20.21M -8.76M -227.84M -221.69M -73.54M -59.63M 17.61M 18.75M 18.75M 87.73M -9.18M -34.49M -50.09M -62.68M -65.14M -74.8M -53.59M -23.07M -12.9M -12.94M -8.1M
Capital Expenditures -85.42M -107.61M -131.54M -119.22M -137.52M -163.41M -144.62M -199.22M -148.38M -227.65M -118.83M -65.12M -44.57M -154.22M -49.46M -89.8M -56.37M -22.41M -24.58M -2.96M -24.07M -5.97M -4.86M -17.81M -3.76M -22.94M -6.4M
Acquisitions n/a n/a n/a -23.65M -23.21M 6.62M 50M 125M -2.79M -910.15M -1.1M -10.76M -1.74M 81M -32.95M -8.37M n/a n/a n/a n/a -14.79M n/a -3.12M n/a n/a -1.5M n/a
Purchase of Investments -410.25M -868.5M -611.81M -937.14M -538.37M -632.02M -634.75M -655.45M -699.75M -876.51M -559.32M -395.04M -387.17M -217.33M -225.29M -439.3M -740.57M -838.86M -219.89M n/a -37.44M -125.08M n/a -94.9M -13.7M -37.6M -1.1M
Sales Maturities Of Investments 633.02M 864.86M 620M 691.05M 555.83M 740.21M 993.73M 425.96M 367.57M 424.71M 808.31M 288.64M 237.84M 281.99M 206.36M 475.31M 777.86M 693.81M 29.91M 26.38M 86.31M 80.07M 78.62M n/a 15.9M n/a n/a
Other Investing Acitivies -853K -10.92M 103.33M 22.65M 89.64M 17.57M -10K -1.75M -698K 410M 65.5M -116.5M -151.07M -81M n/a -17.52M n/a 16.47M 19.8M 34.18M -25.3M 28K 272K -21.2M n/a -6.71M -700K
Investing Cash Flow 136.49M -111.24M -20.03M -366.31M -53.62M -31.03M 264.35M -305.46M -484.05M -1.18B 194.56M -298.78M -195.65M -89.56M -101.34M -79.67M -19.08M -151M -194.77M 57.6M -15.29M -50.95M 70.91M -133.91M -1.55M -68.75M -8.2M
Debt Repayment -494.99M -2.29M -2.6M -3.04M 203.84M -5.09M -374.95M 481.69M n/a n/a n/a 713.24M n/a -879K -195K -74.78M -94K 309.35M 163.12M 177K 293K 118.4M 214K 5.26M 776K 25.59M 100K
Common Stock Repurchased n/a n/a -54.28M -45.8M -50M -42.68M -35.92M -33.51M n/a n/a n/a -6.4M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -31.46M -85.79M -16.05M 2.99M 27.27M -69.59M -13.05M 25.46M 14.17M -23.39M -11.01M 33.43M 76.79M -3.38M 3.7M 11M 22.9M n/a -7.7M 22.13M -30M 485K 1.75M 13.16M n/a n/a -100K
Financial Cash Flow -526.45M -18.73M -18.65M -48K 181.12M -74.67M -388.01M 507.14M 727.11M 927.91M 185.69M 746.67M 312.29M 29M 3.5M -63.79M 22.81M 324.57M 295.94M 30.09M -27.89M 213.47M 3.85M 152.99M 7.57M 95.69M 19.7M
Net Cash Flow 187.72M 30.6M 137.25M -61.88M 211.71M -56.54M -104.05M 189.7M 11.29M -478.45M 306.7M 388.25M 134.25M -41.81M -79.09M -55.73M -5.44M 139.18M 51.07M 25.01M -108.33M 87.77M 21.11M -4M -6.88M 14M 3.4M
Free Cash Flow 475.42M 51.65M 44.36M 185.31M -52.15M -115.14M -124.41M -207.98M -376.22M -449.34M -192.37M -124.76M -26.96M -135.47M -30.71M -2.07M -65.54M -56.91M -74.67M -65.64M -89.22M -80.77M -58.46M -40.88M -16.66M -35.88M -14.5M